These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30592398)

  • 1. Aspirin-Exacerbated Respiratory Disease.
    Kuhn DM
    N Engl J Med; 2018 Dec; 379(23):2281. PubMed ID: 30592398
    [No Abstract]   [Full Text] [Related]  

  • 2. Eosinophilic asthma with nasal polyposis march: Is aspirin-exacerbated respiratory disease the last station?
    Yılmaz İ; Türk M; Bahçecioğlu SN
    J Allergy Clin Immunol Pract; 2017; 5(6):1807-1808. PubMed ID: 29122169
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin-Exacerbated Respiratory Disease.
    Rusznak M; Peebles RS
    N Engl J Med; 2018 Dec; 379(23):2280-2281. PubMed ID: 30592397
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin-Exacerbated Respiratory Disease.
    White AA; Stevenson DD
    N Engl J Med; 2018 Dec; 379(23):2281-2282. PubMed ID: 30575459
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin-Exacerbated Respiratory Disease: A Unique Case of Drug Hypersensitivity.
    Corey KB; Cahill KN
    Immunol Allergy Clin North Am; 2022 May; 42(2):421-432. PubMed ID: 35469627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A graduated approach to management of chronic rhinosinusitis in aspirin-exacerbated respiratory disease in the era of precision medicine.
    Sedaghat AR
    Ann Allergy Asthma Immunol; 2019 Oct; 123(4):325-326. PubMed ID: 31586536
    [No Abstract]   [Full Text] [Related]  

  • 7. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
    Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L
    J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin-exacerbated respiratory disease: personalized medical and surgical approaches.
    Schlosser RJ
    Int Forum Allergy Rhinol; 2020 Sep; 10(9):1035-1036. PubMed ID: 32634286
    [No Abstract]   [Full Text] [Related]  

  • 9. Dysbiosis in aspirin-exacerbated respiratory disease.
    Cook KA; Domissy A; Simon RA; White AA; Modena BD
    Int Forum Allergy Rhinol; 2021 Jul; 11(7):1116-1120. PubMed ID: 33438331
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypereosinophilia following aspirin desensitization for aspirin-exacerbated respiratory disease.
    Pitlick MM; Pongdee T
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2187-2190.e1. PubMed ID: 35598867
    [No Abstract]   [Full Text] [Related]  

  • 11. Current complications and treatment of aspirin-exacerbated respiratory disease.
    Cook KA; Stevenson DD
    Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is aspirin desensitization indicated for the treatment recalcitrant chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease?
    Levy JM; Smith TL
    Laryngoscope; 2017 Apr; 127(4):776-777. PubMed ID: 27813100
    [No Abstract]   [Full Text] [Related]  

  • 13. Readability and quality analysis of patient education materials in aspirin-exacerbated respiratory disease.
    Panara K; Grose E; Lee DJ; Safadi J; Douglas JE; Kohanski MA; Palmer JN; Lee JM; Adappa ND; Bosso JV
    Int Forum Allergy Rhinol; 2023 Dec; 13(12):2259-2261. PubMed ID: 37365855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. If aspirin-exacerbated respiratory disease treatment is a jigsaw puzzle, where do the aspirin and biologic pieces go?
    White AA
    Ann Allergy Asthma Immunol; 2022 May; 128(5):484-485. PubMed ID: 35489798
    [No Abstract]   [Full Text] [Related]  

  • 15. Not just snot: Local inflammatory profiles in patients with aspirin-exacerbated respiratory disease differ from patients with aspirin-tolerant chronic rhinosinusitis.
    Chiang S; Yu SE; Athni TS; Bergmark RW; Maxfield AZ; Roditi RE; Buchheit KM; Lundberg M; Mitchell MB; Lee SE
    Int Forum Allergy Rhinol; 2024 Jan; 14(1):110-113. PubMed ID: 37325975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aspirin-exacerbated respiratory disease: current diagnosis and treatment].
    He SC; Xu YT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Nov; 55(11):1091-1094. PubMed ID: 33210895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age as a factor in treatment of aspirin-exacerbated respiratory disease: relationship to required aspirin maintenance dose after desensitization.
    Locke TB; Sweis AM; Gleeson PK; Lin TC; Civantos AM; Parhar HS; Corr AM; Kumar A; Salmon MK; Kohanski MA; Palmer JN; Bosso JV; Adappa ND
    Int Forum Allergy Rhinol; 2020 Oct; 10(10):1180-1181. PubMed ID: 32761891
    [No Abstract]   [Full Text] [Related]  

  • 18. Eosinophilic granulomatosis with polyangiitis presenting as aspirin-exacerbated respiratory disease.
    Herzberg SD; Bosso AM; Sangal NR; Bosso JV
    Ann Allergy Asthma Immunol; 2023 Oct; 131(4):528-530. PubMed ID: 37487803
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
    Simon RA; Dazy KM; Waldram JD
    Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotriene-Associated Rash in Aspirin-Exacerbated Respiratory Disease.
    Laidlaw TM; Gakpo DH; Bensko JC; Buchheit K
    J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3170-3171. PubMed ID: 32739465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.